Search

Author/Creator Mengarelli, A.

1. Comparison between simulated and observed LHC beam backgrounds in the ATLAS experiment at Ebeam=4 TeV. (4th December 2018)

Authors:
Aaboud, M.; Aad, G.; Abbott, B.; Abdinov, O.; Abeloos, B.; Abidi, S.H.; AbouZeid, O.S.; Abraham, N.L.; Abramowicz, H.; Abreu, H.; Abulaiti, Y.; Acharya, B.S.; Adachi, S.; Adamczyk, L.; Adelman, J.; Adersberger, M.; Adiguzel, A.; Adye, T.; Affolder, A.A.; Afik, Y.
Journal:
Journal of instrumentation
Issue:
Volume 13:Number 12(2018:Dec.)
Page Start:
P12006
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single‐institution study. Issue 6 (5th November 2014)

Authors:
Marchesi, F.; Pimpinelli, F.; Dessanti, M.L.; Gumenyuk, S.; Palombi, F.; Pisani, F.; Romano, A.; Spadea, A.; Maschio, M.; Ensoli, F.; Mengarelli, A.
Journal:
Transplant infectious disease
Issue:
Volume 16:Issue 6(2014)
Page Start:
1032
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. High incidence of post‐transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib‐based regimens: a survey from the Rome Transplant Network. Issue 1 (12th November 2013)

Authors:
Marchesi, F.; Mengarelli, A.; Giannotti, F.; Tendas, A.; Anaclerico, B.; Porrini, R.; Picardi, A.; Cerchiara, E.; Dentamaro, T.; Chierichini, A.; Romeo, A.; Cudillo, L.; Montefusco, E.; Tirindelli, M.C.; De, P.; Annino, L.; Petti, M.C.; Monarca, B.; Arcese, W.; Avvisati, G.
Journal:
Transplant infectious disease
Issue:
Volume 16:Issue 1(2014)
Page Start:
158
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant. Issue 2 (February 2016)

Authors:
Mengarelli, A.; Annibali, O.; Pimpinelli, F.; Riva, E.; Gumenyuk, S.; Renzi, D.; Cerchiara, E.; Piccioni, L.; Palombi, F.; Pisani, F.; Romano, A.; Spadea, A.; Papa, E.; Cordone, I.; Canfora, M.; Arcese, W.; Ensoli, F.; Marchesi, F.
Journal:
Journal of infection
Issue:
Volume 72:Issue 2(2016)
Page Start:
265
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. S208: EFFICACY AND SAFETY OF ZANDELISIB ADMINISTERED BY INTERMITTENT DOSING (ID) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF THE GLOBAL PHASE 2 STUDY TIDAL. (23rd June 2022)

Authors:
Zelenetz, A.; Jurczak, W.; Ribrag, V.; Linton, K.; Collins, G.; Lopéz-Jiménez, J.; Reddy, N.; Mengarelli, A.; Phillips, T.; Musuraca, G.; Sheehy, O.; Li, J.; Xu, W.; Azoulay, M.; Ghalie, R.; Zinzani, P. L.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
109
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗